Blue Light Cystoscopy With Cysview® Registry

NCT02660645 · tracked via the Priya Life Science USA tracker

Sponsor

Photocure

Phase

Observational

Started

2014-04

Last updated

2025-12-18

Condition(s) studied

Bladder Cancer

Investigational drug(s) / intervention(s)

Hexaminolevulinate hydrochloride (HCL)Karl Storz D-Light C Photodynamic Diagnostic (PDD) system

Hexaminolevulinate hydrochloride (HCL): Instillation in bladder

Karl Storz D-Light C Photodynamic Diagnostic (PDD) system: Cystoscopy procedure

Study summary

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Adult \>18 years old * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy Exclusion Criteria: * Porphyria * Gross hematuria * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives

Primary outcome measure(s)

Rate of detection of bladder malignancies — 5 years
Rate of detection of bladder malignancies with Blue Light Cystoscopy with Cysview versus white light cystoscopy alone.

Trial sites (23)

Facility	City	Region	Status
The University of Alabama at Birmingham	Birmingham	Alabama	Recruiting
Mayo Clinic	Phoenix	Arizona	Recruiting
USC/Norris Comprehensive Cancer Center	Los Angeles	California	Recruiting
University of California Los Angeles	Los Angeles	California	Recruiting
VA Palo Alto Health Care System	Palo Alto	California	Recruiting
University of California, San Francisco	San Francisco	California	Recruiting
Sibley Memorial Hospital	Washington D.C.	District of Columbia	Recruiting
Emory University School of Medicine	Atlanta	Georgia	Recruiting
Northwestern University	Chicago	Illinois	Recruiting
Northshore University Health System	Evanston	Illinois	Recruiting
Indiana University School of Medicine	Indianapolis	Indiana	Recruiting
University of Kansas Medical Center	Kansas City	Kansas	Recruiting
Johns Hopkins Medicine	Baltimore	Maryland	Recruiting
University of Minnesota	Minneapolis	Minnesota	Recruiting
NYU Langone's Perlmutter Cancer Center	New York	New York	Recruiting
Stony Brook Urology	Stony Brook	New York	Suspended
Ohio State University Wexner Medical Center	Columbus	Ohio	Recruiting
Ohio State University	Columbus	Ohio	Recruiting
Lexington Medical Center	West Columbia	South Carolina	Recruiting
UT Southwestern	Dallas	Texas	Recruiting
Michael E. DeBakey VA Medical Center	Houston	Texas	Recruiting
University of Washington Medicine	Seattle	Washington	Recruiting
Charleston Area Medical Center	Charleston	West Virginia	Terminated

More Photocure trials in the USA

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy Recruiting

Other trials for the same condition

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) Recruiting

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer Active, not recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) Recruiting

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Active, not recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02660645 on ClinicalTrials.gov ↗ ← All trials in the USA